Evidence map›Paper›PMID 40148272›Full record

ArticleNature communications2025

CUT&Tag recovers up to half of ENCODE ChIP-seq histone acetylation peaks.

Leyla Abbasova, Paulina Urbanaviciute, Di Hu, Joy N Ismail, Brian M Schilder, Alexi Nott, Nathan G Skene, Sarah J Marzi

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Leyla Abbasova *UK Dementia Research Institute at Imperial College London, London, UK.ORCID http://orcid.org/0000-0003-0206-9506
Paulina Urbanaviciute *UK Dementia Research Institute at King's College London, London, UK.
Di Hu *UK Dementia Research Institute at Imperial College London, London, UK.
Joy N IsmailUK Dementia Research Institute at King's College London, London, UK.
Brian M SchilderUK Dementia Research Institute at Imperial College London, London, UK.
Alexi NottUK Dementia Research Institute at Imperial College London, London, UK.ORCID http://orcid.org/0000-0002-2029-7193
Nathan G SkeneUK Dementia Research Institute at Imperial College London, London, UK.
Sarah J MarziDepartment of Brain Sciences, Imperial College London, London, UK. sarah.marzi@kcl.ac.uk.ORCID http://orcid.org/0000-0002-3924-2053

Funding

Alzheimer's Association ADSF-21-829660-CRCUK | Medical Research Council (MRC) MR/W004984/1
6 · The paper itself

Abstract

DNA-protein interactions have traditionally been profiled via chromatin immunoprecipitation followed by next-generation sequencing (ChIP-seq). Cleavage Under Targets & Tagmentation (CUT&Tag) is a rapidly expanding technique that enables the profiling of such interactions in situ at high sensitivity. However, thorough evaluation and benchmarking against established ChIP-seq datasets are lacking. Here, we comprehensively benchmarked CUT&Tag for H3K27ac and H3K27me3 against published ChIP-seq profiles from ENCODE in K562 cells. Combining multiple new and published CUT&Tag datasets, there was an average recall of 54% known ENCODE peaks for both histone modifications. We tested peak callers MACS2 and SEACR and identified optimal peak calling parameters. Overall, peaks identified by CUT&Tag represent the strongest ENCODE peaks and show the same functional and biological enrichments as ChIP-seq peaks identified by ENCODE. Our workflow systematically evaluates the merits of methodological adjustments, providing a benchmarking framework for the experimental design and analysis of CUT&Tag studies.

Indexed as

Chromatin Immunoprecipitation SequencingHistonesAcetylationChromatin ImmunoprecipitationHigh-Throughput Nucleotide SequencingHistone CodeHumansK562 CellsHistones

Identifiers

PMID40148272
PMCPMC11950320

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.